Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group Study

✍ Scribed by Janine L. Mansi; Ann Yellowlees; Julian Lipscombe; Helena M. Earl; David A. Cameron; Robert E. Coleman; Timothy Perren; Christopher J. Gallagher; Mary Quigley; John Crown; Alison L. Jones; Martin Highley; Robert C. F. Leonard; T. R. Jeffry Evans

• Publisher: Springer US
• Year: 2010
• Tongue: English
• Weight: 253 KB
• Volume: 122
• Category: Article
• ISSN: 0167-6806
• DOI: 10.1007/s10549-010-0989-6